最终persevERA三期研究仍未能达到主要终点，无法显著改善患者的无进展生存期（PFS）。这意味着，它无法证明自己比现有的激素疗法更好，失去了成为一线治疗首选药物的可能。
СюжетКурс доллара:
More like this:。wps对此有专业解读
Follow topics & set alerts with myFT，这一点在谷歌中也有详细论述
"I'm absolutely thrilled and maybe I'll [get] quite a few invites to conventions and various things."
FT App on Android & iOS，更多细节参见超级权重